⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL8167089 | 0.83 | FFAR3 (0.37) | — | |
| SCHEMBL148914 | 0.78 | — | — | |
| SCHEMBL846055 | 0.78 | — | — | |
| SCHEMBL29131062 | 0.74 | — | — | |
| SCHEMBL29165409 | 0.74 | — | — | |
| SCHEMBL28662436 | 0.74 | — | — | |
| Methyl Alcohol SCHEMBL28712278 | 0.70 | — | — | |
| SCHEMBL28984742 | 0.70 | — | — | |
| SCHEMBL11319167 | 0.67 | ALDH1A1 (0.33) | — | |
| SCHEMBL9723500 | 0.67 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260130860-A1 | LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS | FLAGSHIP LABS 114, INC. (US) | 2026-05-14 | — | — | US | disclosed |
| EP-4633734-A1 | COMPOUNDS, COMPOSITIONS, AND MEZHODS OF TREATING DISORDERS ASSOCIATED WITH PROTEIN MISFOLDING | Wavebreak Therapeutics, LLC (US) | 2025-10-22 | — | — | EP | disclosed |
| US-20250084044-A1 | PROTOPORPHYRINOGEN OXIDASE INHIBITORS | ENKO CHEM, INC. (US) | 2025-03-13 | — | — | US | disclosed |
| EP-4462999-A1 | PROTOPORPHYRINOGEN OXIDASE INHIBITORS | Enko Chem, Inc. (US) | 2024-11-20 | — | — | EP | disclosed |
| CN-118541030-A | Protoporphyrinogen oxidase inhibitors | 恩科化学公司 | 2024-08-23 | — | — | CN | disclosed |
| WO-2024129881-A1 | COMPOUNDS, COMPOSITIONS, AND MEZHODS OF TREATING DISORDERS ASSOCIATED WITH PROTEIN MISFOLDING | WAVEBREAK THERAPEUTICS LIMITED (US) | 2024-06-20 | — | — | WO | disclosed |
| WO-2023225621-A2 | LIPIDS FOR DELIVERY OF THERAPEUTIC AGENTS | OMEGA THERAPEUTICS, INC. (US) | 2023-11-23 | — | — | WO | disclosed |
| WO-2023137307-A1 | PROTOPORPHYRINOGEN OXIDASE INHIBITORS | ENKO CHEM, INC. (US) | 2023-07-20 | — | — | WO | disclosed |
| US-20210179546-A1 | METHODS AND COMPOSITIONS FOR TERPENOID TRICYCLOALKANE SYNTHESIS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2021-06-17 | — | — | US | disclosed |
| CN-102816142-A | Synthesis method for pentadecanoicacid | FUJIAN TIANFU BIOTECHNOLOGY DEV CO LTD | 2012-12-12 | — | — | CN | disclosed |
| US-20120136057-A1 | HYDROXY FATTY ACID COMPOUNDS AND USES THEREOF FOR DISEASE TREATMENT AND DIAGNOSIS | PHENOMENOME DISCOVERIES INC. (CA) | 2012-05-31 | — | — | US | disclosed |
| CN-101486704-A | Method for synthesizing muscolide | YIWEN QI (CN) | 2009-07-22 | — | — | CN | disclosed |
| US-20020155443-A1 | Metal binding DNA interactive compounds | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2002-10-24 | — | — | US | disclosed |
| EP-0862559-A1 | NOVEL FLUORINATED OR HYDROXYLATED PHENYLIMIDAZOLIDINES HAVING ANTI-ANDROGENIC ACTIVITY, METHOD FOR PREPARING SAME, RESULTING INTERMEDIATES, AND PHARMACEUTICAL COMPOSITIONS | HOECHST MARION ROUSSEL (FR) | 1998-09-09 | — | — | EP | disclosed |
| WO-1997019064-A1 | NOVEL FLUORINATED OR HYDROXYLATED PHENYLIMIDAZOLIDINES HAVING ANTI-ANDROGENIC ACTIVITY, METHOD FOR PREPARING SAME, RESULTING INTERMEDIATES, AND PHARMACEUTICAL COMPOSITIONS | HOECHST MARION ROUSSEL (FR) | 1997-05-29 | — | — | WO | disclosed |
| EP-0318214-B1 | Tri- and tetra-substituted-oxetanes and -tetrahydrofurans and intermediates thereof | SCHERING CORP (US) | 1994-12-14 | — | — | EP | disclosed |
| US-5039676-A | Fungicide, antiallergens | SCHERING CORPORATION (US) | 1991-08-13 | — | — | US | disclosed |
| EP-0386143-A1 | TRI- AND TETRA-SUBSTITUTED-OXETANES AND TETRAHYDROFURANS AND INTERMEDIATES THEREOF | SCHERING CORPORATION (US) | 1990-09-12 | — | — | EP | disclosed |
| WO-1989004829-A1 | TRI- AND TETRA-SUBSTITUTED-OXETANES AND TETRAHYDROFURANS AND INTERMEDIATES THEREOF | SCHERING CORPORATION (US) | 1989-06-01 | — | — | WO | disclosed |
| EP-0318214-A1 | Tri- and tetra-substituted-oxetanes and -tetrahydrofurans and intermediates thereof | SCHERING CORPORATION (US) | 1989-05-31 | — | — | EP | disclosed |